RPS15A and lung adenocarcinoma: The immunopositive rates of RPS15A in lung adenocarcinoma and normal lung tissues were 66.7% (50/75) and 42.7% (32/75), indicating that RPS15A was highly expressed in lung cancer in comparison with adjacent normal tissues, as shown in Table 1 (P < 0.001).